APEX MEDICAL Press Release
Taipei, Taiwan – 30th June 2017. Apex Medical Corp. (APEX), (TWSE listed Company (ref code 4106) announced today that it has completed the acquisition of NEXUS DMS Limited, a leading UK provider of specialist healthcare profiling beds to both the community and acute markets effective from the 30th of June 2017. The acquisition shows Apex Medical Corp.’s ambition to progress and further develop its product and service offering, bringing enhanced value to new and existing customers alike.
Nicola Rodker, APEX Medical UK Managing Director commented “The acquisition of NEXUS DMS Limited will further strengthen APEX Medical’s presence in the UK market, offering us a greater range of specialist products and strengthening our service capabilities so we can increase our offering to our valued customers. All of us at APEX Medical are very excited by the acquisition and look forward to welcoming all the staff at NEXUS DMS to the APEX family.”
“As part of this acquisition APEX will significantly enhance its offering to the UK market place and support the provision of world-class products and services to its customer base across the UK.”
NEXUS DMS will continue to operate under its current management structure, led by Managing Director Simon Robinson who will now report directly into the APEX Medical senior management team.
NEXUS DMS Limited was founded by John Robinson and has grown to become a leading supplier of specialist therapy, acute and post-acute profiling beds and mattresses in the UK.
John Robinson commented “NEXUS DMS Limited has built its business up believing that good quality customer service and exceptional product offering are two of the most important foundation stones to any business in the sector, these are principles that are very much shared by APEX Medical, and will help us to continue to grow together in the future.”
In recent years, APEX has rapidly established regional subsidiaries and a consolidated service network in Europe, America, China, and India to provide direct service aligned to regional requirements. APEX continues towards significant and sustained growth all over the world by providing healthcare solutions to both improve patients’ quality of life and reduce total healthcare cost.
Apex Medical is a leading manufacturer of its own brand of Wound Management and Respiratory Therapy products and distributes its products through an established network of international subsidiaries and partners in Europe, the United States, Asia and other international markets.
APEX Medical specialises in product development, engineering and marketing products with a dedicated and innovative team of industry professionals. APEX aims to be a global leader in the provision of high quality healthcare products, delivering tested, trialed and clinically evaluated devices while ensuring that its own technology and intellectual property meet the demands of the Wound Management, Respiratory Therapy and Moving and Handling markets.